SCHEMBL22115355

SCHEMBL22115355

c1ccc(-c2ccc(-c3ccc4c(-c5ccccc5)c5ccccc5c(-c5ccccc5)c4c3)c3ccccc23)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 2/20 0.40
ACHE P22303 2/20 0.39
ESR2 Q92731 5/20 0.39
ESR1 P03372 4/20 0.39
BACE1 P56817 1/20 0.38
ALOX5 P09917 1/20 0.38
PIK3CA P42336 1/20 0.38
MAPT P10636 4/20 0.37
HPGD P15428 2/20 0.37
KDM4E B2RXH2 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
ALDH1A1 P00352 1/20 0.37
MPI P34949 1/20 0.37
HTT P42858 3/20 0.36
MAPK1 P28482 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
HSD17B1 P14061 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21571883 0.88 ACHE (0.37) GPR84ACHEESR2ESR1ALOX5
SCHEMBL29662092 0.87 ACHE (0.45) ACHEESR2ESR1ALOX5MAPT
SCHEMBL994958 0.87 ACHE (0.45) ACHEESR2ESR1ALOX5MAPT
SCHEMBL26473757 0.86 PIK3CA (0.41) GPR84ACHEESR2ESR1BACE1
SCHEMBL5474574 0.86 MCL1 (0.48) ESR2ESR1MAPTHPGDKDM4E
SCHEMBL28537602 0.85 MCL1 (0.50) ESR2ESR1MAPTHPGDKDM4E
SCHEMBL23056792 0.85 ACHE (0.43) ACHEESR2ESR1ALOX5MAPT
SCHEMBL21435747 0.85 ESR2 (0.46) ACHEESR2ESR1ALOX5MAPT
SCHEMBL2964995 0.85 ESR2 (0.46) ACHEESR2ESR1ALOX5MAPT
SCHEMBL19283276 0.85 ESR2 (0.46) ACHEESR2ESR1ALOX5MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11737358-B2 Compound and organic light emitting device comprising same LG CHEM, LTD. (KR) 2023-08-22 US disclosed
US-10950801-B2 Organic light-emitting device LG CHEM, LTD. (KR) 2021-03-16 US disclosed
US-20200303655-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2020-09-24 US disclosed
US-20200287142-A1 ORGANIC LIGHT-EMITTING DEVICE LG CHEM LTD. (KR) 2020-09-10 US disclosed
EP-3667749-A1 ORGANIC LIGHT-EMITTING DEVICE LG CHEM, LTD. (KR) 2020-06-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11737358-B2 Compound and organic light emitting device comprising same ARNT, CYP1A1, AHR GPR84 1341/4885ACHE 1978/4885ESR2 114/4885
US-20200303655-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME ARNT, CYP1A1, AHR GPR84 1341/4885ACHE 1978/4885ESR2 114/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.